EAPCI Core Curriculum for Percutaneous Cardiovascular Interventions (2020): Committee for Education and Training European Association of Percutaneous Cardiovascular Interventions (EAPCI). A branch of the European Society of Cardiology

Eric Van Belle*, Rui C. Teles, European Society of Cardiology, Committee for Education and Training of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), Stylianos A. Pyxaras, Oliver Kalpak, Thomas Johnson, Israel Moshe Barbash, Giuseppe De Luca, Jorgo Kostov, Radoslaw Parma, Flavien Vincent, Salvatore Brugaletta, Nicolas Debry, Gabor G. Toth, Ziyad Ghazzal, Pierre Deharo, Dejan Milasinovic, Klaus Kaspar, Francesco SaiaJosepa Mauri, Jürgen Kammler, Douglas Muir, Stephen O'Connor, Julinda Mehilli, Holger Thiele, Daniel Weilenmann, Nils Witt, Francis Joshi, Rajesh Kharbanda, Zsolt Piroth, Wojciech Wojakowski, Alexander Geppert, Giuseppe Di Gioia, Gustavo Pires-Morais, Anna Sonia Petronio, Rodrigo Estévez-Loureiro, Zoltan Ruzsa, Joelle Kefer, Vijay Kunadian, Nicolas Van Mieghem, Stephan Windecker, Andreas Baumbach, Michael Haude, Dariusz Dudek

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

6 Citations (Scopus)
13 Downloads (Pure)

Abstract

The proposed 2020 Core Curriculum for Percutaneous Cardiovascular Interventions aims to provide an updated European consensus that defines the level of experience and knowledge in the field of percutaneous cardiovascular intervention (PCI). It promotes homogenous education and training programmes among countries, and is the cornerstone of the new EAPCI certification, designed to support the recognition of competencies at the European level and the free movement of certified specialists in the European Community. It is based on a thorough review of the ESC guidelines and of the EAPCI textbook on percutaneous interventional cardiovascular medicine. The structure of the current core curriculum evolved from previous EAPCI core curricula and from the "2013 core curriculum of the general cardiologist"to follow the current ESC recommendations for core curricula. In most subject areas, there was a wide - if not unanimous - consensus among the task force members on the training required for the interventional cardiologist of the future. The document recommends that acquisition of competence in interventional cardiology requires at least two years of postgraduate training, in addition to four years devoted to cardiology. The first part of the curriculum covers general aspects of training and is followed by a comprehensive description of the specific components in 54 chapters. Each of the chapters includes statements of the objectives, and is further subdivided into the required knowledge, skills, behaviours, and attitudes.

Original languageEnglish
Pages (from-to)23-31
Number of pages9
JournalEuroIntervention
Volume17
Issue number1
Early online dateJul 2020
DOIs
Publication statusPublished - May 2021

Bibliographical note

Funding Information:
A. Baumbach received institutional research support from Abbott Vascular, consultation and speaker fees from AstraZeneca, Sinomed, MicroPort, Abbott Vascular, Cardinal Health, KSH, and Medtronic. R. Estevez-Loureiro reports grants and personal fees from Abbott Vascular and personal fees from Boston Scientific, outside the submitted work. A. Geppert reports lecture fees from Medtronic, Abbott and Abiomed, consulting fees from Abbott and Abiomed, congress grants from Asahi and Terumo, outside the submitted work. J. Kefer reports proctorship and speaker fees from Medtronic and Abbott, and speaker fees from Servier. D. Milasinovic reports personal fees from Abbot, Biosensors, Terumo, AstraZeneca and Sanofi, outside the submitted work. D. Muir is a proctor and advisory board member for Abbott Vascular, and received proctor, advisory board and speaker fees from Edwards Lifesciences. A.S. Petronio received proctor and advisory board fees from Abbott Vascular, and received proctor, advisory board and speaker fees from Edwards Lifesciences. G. Pires-Morais received speaker fees from Abbott Vascular. S. Pyxaras received consultancy fees from Abiomed and Boston Scientific and proctor fees from Boston Scientific. R. Parma received speaker fees from Boston Scientific, Edwards Lifesciences and Medtronic. F. Saia reports personal fees from Abbott Vascular, Boston Scientific, Edwards, Medtronic, Biotronik, Amgen, AstraZeneca, Daiichi Sankyo, Bayer and Boehringer-Ingelheim, outside the submitted work. N. Van Mieghem reports advisor fees from PulseCath BV and Abiomed. S. Windecker reports grants from Abbott, Amgen, BMS, Bayer, Boston Scientific, Biotronik, Cardinal Health, CSL Behring, Daiichi Sankyo, Edwards Lifesciences, Johnson and Johnson, Medtronic, Quebert, Polares, Sanofi and Terumo, outside the submitted work. E. Van Belle reports personal fees from HeartFlow and Philips, outside the submitted work. The other authors have no conflicts of interest to declare.

Publisher Copyright:
© Europa Digital & Publishing 2021. All rights reserved.

Fingerprint

Dive into the research topics of 'EAPCI Core Curriculum for Percutaneous Cardiovascular Interventions (2020): Committee for Education and Training European Association of Percutaneous Cardiovascular Interventions (EAPCI). A branch of the European Society of Cardiology'. Together they form a unique fingerprint.

Cite this